PAYS - Tingkat wutah pendapatan YoY sajrone rolas wulan kepungkur Paysign, Inc.

Paysign, Inc. (PAYS) dominates the plasma donor payment niche, expanding its corporate segment and float income. A key driver is the creation of payment ecosystems through co-branding with pharmaceutical brands, which is confirmed by the current year-over-year (TTM) revenue growth rate. Business stability relies on biomaterial collection volumes in the US while managing dependence on major clients. The value of 47.40 shows the current value of the metric.
Ringkesan rincian data analitis 3DIcon (PAYS)

This indicator calculates revenue dynamics over a rolling twelve-month period, providing continuous monitoring of business expansion without quarterly pauses. By analyzing the YoY sales growth over the last four quarters, an investor assesses the actual scaling pace of Paysign, Inc. (PAYS) fintech solutions within the pharmaceutical sector and government programs, where payment processing speed directly determines market share and the company's capitalization potential.